Australia markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
20.83-0.30 (-1.42%)
As of 09:38AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.15-0.39-0.39-0.6
Low estimate-0.19-0.61-0.65-0.66
High estimate-0.09-0.19-0.22-0.55
Year ago EPS-0.390.28-0.41-0.39
Revenue estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate71.72M74.86M281.39M321.77M
Low estimate70.7M74M280.2M310.55M
High estimate72.32M76.13M282.3M339.56M
Year ago sales84.69M70.5M289.21M281.39M
Sales growth (year/est)-15.30%6.20%-2.70%14.40%
Earnings history29/09/202330/12/202330/03/202429/06/2024
Est. EPS-0.33-0.29-0.32-0.3
Actual EPS-0.390.28-0.010.15
Difference-0.060.570.310.45
Surprise %-18.20%196.60%96.90%150.00%
EPS trendCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Current estimate-0.15-0.39-0.39-0.6
7 days ago-0.15-0.39-0.39-0.6
30 days ago-0.15-0.39-0.39-0.6
60 days ago-0.24-0.37-0.92-0.85
90 days ago-0.24-0.37-0.92-0.85
EPS revisionsCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesFLGTIndustrySector(s)S&P 500
Current qtr.61.50%N/AN/AN/A
Next qtr.-239.30%N/AN/AN/A
Current year4.90%N/AN/AN/A
Next year-53.80%N/AN/AN/A
Next 5 years (per annum)-52.25%N/AN/AN/A
Past 5 years (per annum)21.67%N/AN/AN/A